|
|
Volumn 17, Issue 1, 2016, Pages
|
|
FourFold Asthma Study (FAST): A study protocol for a randomised controlled trial evaluating the clinical cost-effectiveness of temporarily quadrupling the dose of inhaled steroid to prevent asthma exacerbations
a
|
|
Author keywords
Asthma; Exacerbation; Fourfold; Inhaled corticosteroids; Oral corticosteroids Randomised controlled trial; Primary care; Protocol; Self management plan
|
|
Indexed keywords
BECLOMETASONE DIPROPIONATE;
BECLOMETASONE DIPROPIONATE PLUS FORMOTEROL FUMARATE;
BUDESONIDE;
BUDESONIDE PLUS FORMOTEROL;
CICLESONIDE;
CORTICOSTEROID;
FLUTICASONE PROPIONATE PLUS FORMOTEROL FUMARATE;
FLUTICASONE PROPIONATE PLUS SALMETEROL XINAFOATE;
ANTIASTHMATIC AGENT;
ARTICLE;
ASTHMA;
CLINICAL EFFECTIVENESS;
CONTROLLED STUDY;
COST EFFECTIVENESS ANALYSIS;
DISEASE EXACERBATION;
DRUG DOSE INCREASE;
DRY POWDER INHALER;
FOLLOW UP;
HEALTH CARE UTILIZATION;
HUMAN;
METERED DOSE INHALER;
MULTICENTER STUDY;
MULTICENTER STUDY (TOPIC);
RANDOMIZED CONTROLLED TRIAL;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
SAMPLE SIZE;
SELF CARE;
UNITED KINGDOM;
ADOLESCENT;
ADULT;
CLINICAL PROTOCOL;
CLINICAL TRIAL;
COST BENEFIT ANALYSIS;
DRUG COST;
DRUG EFFECTS;
ECONOMICS;
FEMALE;
INHALATIONAL DRUG ADMINISTRATION;
LUNG;
MALE;
METHODOLOGY;
ORAL DRUG ADMINISTRATION;
PATHOPHYSIOLOGY;
TIME FACTOR;
TREATMENT OUTCOME;
YOUNG ADULT;
ADMINISTRATION, INHALATION;
ADMINISTRATION, ORAL;
ADOLESCENT;
ADRENAL CORTEX HORMONES;
ADULT;
ANTI-ASTHMATIC AGENTS;
ASTHMA;
CLINICAL PROTOCOLS;
COST-BENEFIT ANALYSIS;
DISEASE PROGRESSION;
DRUG COSTS;
FEMALE;
HUMANS;
LUNG;
MALE;
RESEARCH DESIGN;
SELF CARE;
TIME FACTORS;
TREATMENT OUTCOME;
UNITED KINGDOM;
YOUNG ADULT;
|
|
EID: 84992109614
PISSN: None
EISSN: 17456215
Source Type: Journal
DOI: 10.1186/s13063-016-1608-6 Document Type: Article |
|
Times cited : (4)
|
|
References (11)
|
